longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Bristol Myers Squibb

BMY

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 13.78, within the reasonable range, cheaper than 64.7% of the time in the past 5 years, and the industry ranks 21/257, the industry Median -1.38.

13.78xP/E
$62.62Stock price
$4.54Earnings per share
13.78xP/E
Stock price$62.62Earnings per share$4.54

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
16.66x
Typical range
-13.65x–22.27x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0306090120

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BMYUSBristol Myers Squibb
13.78x62.25%$127.91B
GSKUSGSK
16.15x6.56%$104.09B
UCBJYUSUCB S.A.
18.24x--$46.45B
HLNUSHaleon
19.00x2.64%$41.23B
OTSKYUSOtsuka Pharmaceutical
14.35x--$37.15B
ZTSUSZoetis
11.18x6.81%$29.48B
ALPMYUSAstellas Pharma
11.70x--$27.27B
JAZZUSJazz Pharma
16.66x349.11%$15.67B
OPHLYUSOno Pharmaceutical
14.91x--$7.26B
INDVUSIndivior Pharmaceuticals
11.78x126.83%$4.19B
OGNUSOrganon
17.19x211.11%$3.59B
SNPHYUSSanten Pharmaceutical
14.22x--$3.51B
HRMYUSHarmony Biosciences
13.53x45.48%$2.45B
PBHUSPrestige Brands
12.89x7.48%$2.22B
ANIPUSANI Pharma
17.79x49.55%$1.77B
GTBIFUSGreen Thumb Industries Inc.
13.36x--$1.69B
PAHCUSPhibro Animal Health
14.12x26.75%$1.41B
OMERUSOmeros
10.72x1,880.00%$1.34B
CRONUSCronos
17.53x902.68%$1.23B
AMPHUSAmphastar Pharma
13.26x6.90%$1.04B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.